Loading…
Abstract TP45: Mechanical Thrombectomy for Acute Ischemic Stroke in Patients Over 80 Years in a Real Clinical Practice: Give All a Chance?
Abstract only Introduction: Randomized trials showed a certain benefit of mechanical thrombectomy (MT) also in selected patients over 80 years, however data about non-selected population from a real clinical practice are missing. Thus, we aimed to report outcomes of patients over 80 years and compar...
Saved in:
Published in: | Stroke (1970) 2019-02, Vol.50 (Suppl_1) |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Abstract only
Introduction:
Randomized trials showed a certain benefit of mechanical thrombectomy (MT) also in selected patients over 80 years, however data about non-selected population from a real clinical practice are missing. Thus, we aimed to report outcomes of patients over 80 years and compared them to younger ones.
Methods:
Retrospective analysis involved all patients treated with MT (stent-retrievers) in both centers in 2010-2017. Neurological deficit was assessed with the National Institutes of Health Stroke Scale (NIHSS) and final outcome after 3 months using the modified Rankin scale (mRS); good clinical outcome was scored 0-2. The achieved recanalization was rated with Thrombolysis in Cerebral Infarction (TICI) scale. Presence of symptomatic intracerebral hemorrhage (SICH) was assessed according to the SITS- MOST criteria.
Results:
Of 703 enrolled patients, 138 (19.6%) were over 80 years (52 males, mean age 84 ± 3.4 years) with a median admission NIHSS of 18 points. Recanalization (TICI 2b-3) was achieved in 107 (77.5%) patients, SICH in 8 (5.8%) and good clinical outcome in 47 (34.1%) patients. 59 (42.8 %) patients died within 3 months. No difference was found in rate of achieved recanalization (p-0.38) and SICH (p-0.67) between patients over 80 years and patients aged 65-80 years, but the rate of mRS 0-2 was lower (p-0.004) and mortality higher (p-0.001) in older patients.
Conclusion:
MT seems to be beneficial also in patients over 80 years however, it is associated with higher mortality related to age.
Acknowledgment:
Supported by the grant of MH CR n. 17-30101A, IGA LF UP_018_2018 and KZ- IGA-KZ-2017-1-2. |
---|---|
ISSN: | 0039-2499 1524-4628 |
DOI: | 10.1161/str.50.suppl_1.TP45 |